IDSA News - March 2015  (Plain Text Version)

Return to Graphical Version


In this issue:
•  Public Comment Period for IDSA/AAN/ACR Lyme Guideline Project Plan Closes April 9
•  FDA Approves New Drugs, Cresemba and Avycaz
•  NIH Training Opportunity: Biosafety Officer in High-Containment Facility
•  IDSA Joins the “Choosing Wisely” Campaign to Cut Back on Unnecessary Medical Care
•  New Forum for Contracting and Negotiations Information Exchange
•  IDSA Advances Priorities in 21st Century Cures Legislation
•  HIVMA Receives CAEAR Coalition Partnership Award
•  New Statement on Criminalization of HIV and other Communicable Diseases
•  ID Funding Highlighted on Capitol Hill
•  Laboratory Developed Tests: Regulation Should Keep Pace With ID Patient Needs
•  IDSA Responds to NIH on Proposed Regulatory Process for Multi-Site Research Trials
•  NIAID Launches ClinRegs Website on International Clinical Research Regulations
•  Science Speaks: Coverage of CROI 2015
Education and Resources
•  ABIM MOC Changes
•  Free IDSA Hepatitis C MOC Module
•  IDSA to Offer Infection Control MOC Pre-Meeting Workshop at SHEA Spring Meeting
•  OFID is Now Indexed in PMC
•  Apply Now for IDSA Fellow Advancement
•  IDSA Begins Search for CID Editor-in-Chief
•  Members on the Move
•  New Members
From the President
•  Regaining Ground on Measles Eradication: The Role of the ID Specialist
Top Stories
•  Clinicians: Here’s How to Avoid a Payment Penalty in 2017
•  IDWeek Advance Registration Now Open for IDSA Members
•  IDSA Journal Club


Public Comment Period for IDSA/AAN/ACR Lyme Guideline Project Plan Closes April 9

IDSA, the American Academy of Neurology (AAN), and the American College of Rheumatology (ACR) are requesting input on a project plan that lays the ground work for new Lyme disease guidelines.

The 30-day open public comment period on the Lyme Disease Project Plan is from March 9 to April 9.  The project plan will be available on the IDSA website between these two dates.  During the public comment period, anyone may comment on any aspect of the plan. All comments must be submitted through this link.

For more information, visit the IDSA website.